B-CELL MALIGNANCIES
Clinical trials for B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Swiss hospital tests 'Double-Target' immune therapy for tough blood cancers
Disease control Not yet recruitingThis early-stage trial is testing the safety of a new, locally-made CAR-T cell therapy designed to attack two targets (CD19 and CD20) on cancer cells. It is for adults with advanced B-cell leukemias or lymphomas who have relapsed after or cannot access standard treatments, includ…
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Cancer-Fighting mRNA tech tested in patients out of options
Disease control Not yet recruitingThis early-stage study is testing a new experimental drug called WGb-0301 for people with advanced B-cell cancers (like certain leukemias and lymphomas) that have come back or stopped responding to standard treatments. The drug uses mRNA technology—similar to that in some COVID-1…
Matched conditions: B-CELL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists search for hidden clues in blood cancers
Knowledge-focused Not yet recruitingThis study aims to observe and measure two specific proteins, CD85d and CD305, in the blood cells of 180 people newly diagnosed with B-cell cancers. The goal is to understand if these proteins can help doctors better classify the specific type of cancer and predict when a patient…
Matched conditions: B-CELL MALIGNANCIES
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC